Literature DB >> 10336431

Monoclonal antibodies that inhibit the transport function of the 190-kDa multidrug resistance protein, MRP. Localization of their epitopes to the nucleotide-binding domains of the protein.

D R Hipfner1, Q Mao, W Qiu, E M Leslie, M Gao, R G Deeley, S P Cole.   

Abstract

Multidrug resistance in tumor cells is often accompanied by overexpression of multidrug resistance protein (MRP), a 190-kDa transmembrane protein that belongs to the ATP-binding cassette superfamily of transport proteins. MRP mediates ATP-dependent transport of a variety of conjugated organic anions and can also transport several unmodified xenobiotics in a glutathione-dependent manner. To facilitate structure-function studies of MRP, we have generated a panel of MRP-specific monoclonal antibodies (mAbs). Four of these mAbs, QCRL-2, -3, -4, and -6, bind intracellular conformation-dependent epitopes, and we have shown that they can inhibit the transport of several MRP substrates. Binding competition and immunoprecipitation assays indicated that mAbs QCRL-4 and -6 probably recognize the same detergent-sensitive epitope in MRP, whereas mAbs QCRL-2, -3, and -4 each bind distinct, non-overlapping epitopes. Fab fragments inhibit transport as effectively as the intact mAbs, suggesting that inhibition results from direct interactions of the mAbs with MRP. Immunodot blot and immunoprecipitation analyses revealed that the minimal regions of MRP sufficient for full reactivity of mAbs QCRL-2 and -3 are amino acids 617-858 and 617-932, respectively, which encompass the NH2-proximal nucleotide-binding domain (NBD). In contrast, the epitope bound by mAb QCRL-4 localized to amino acids 1294-1531, a region that contains the COOH-proximal NBD. However, none of the mAbs inhibited photolabeling of intact MRP with 8-azido-[alpha-32P]ATP. This suggests that rather than preventing nucleotide binding, the mAbs inhibit transport by interfering with substrate binding or by trapping MRP in a conformation that does not allow transport to occur. Our results also demonstrate for the first time that the NBDs of MRP can be expressed as soluble polypeptides that retain a native conformation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336431     DOI: 10.1074/jbc.274.22.15420

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Cytosolic delivery of inhibitory antibodies with cationic lipids.

Authors:  Hejia Henry Wang; Andrew Tsourkas
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

2.  Cellular Stiffness as a Novel Stemness Marker in the Corneal Limbus.

Authors:  Tom Bongiorno; Jena L Chojnowski; James D Lauderdale; Todd Sulchek
Journal:  Biophys J       Date:  2016-10-18       Impact factor: 4.033

3.  Expression and function of human MRP1 (ABCC1) is dependent on amino acids in cytoplasmic loop 5 and its interface with nucleotide binding domain 2.

Authors:  Surtaj H Iram; Susan P C Cole
Journal:  J Biol Chem       Date:  2010-12-20       Impact factor: 5.157

4.  Inhibition of the MRP1-mediated transport of the menadione-glutathione conjugate (thiodione) in HeLa cells as studied by SECM.

Authors:  Dipankar Koley; Allen J Bard
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-07       Impact factor: 11.205

5.  Regression of prostate cancer xenografts by RLIP76 depletion.

Authors:  Sharad S Singhal; Cherice Roth; Kathryn Leake; Jyotsana Singhal; Sushma Yadav; Sanjay Awasthi
Journal:  Biochem Pharmacol       Date:  2008-11-25       Impact factor: 5.858

Review 6.  Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution.

Authors:  Thomas Gerloff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-04       Impact factor: 3.000

7.  The role of multidrug resistance protein 1 (MRP1) in transport of fluorescent anions across the human erythrocyte membrane.

Authors:  B Rychlik; A Balcerczyk; A Klimczak; G Bartosz
Journal:  J Membr Biol       Date:  2003-05-15       Impact factor: 1.843

8.  RLIP depletion induces apoptosis associated with inhibition of JAK2/STAT3 signaling in melanoma cells.

Authors:  Sharad S Singhal; Atish Mohanty; Prakash Kulkarni; David Horne; Sanjay Awasthi; Ravi Salgia
Journal:  Carcinogenesis       Date:  2021-05-28       Impact factor: 4.944

9.  RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer.

Authors:  Kathryn Leake; Jyotsana Singhal; Lokesh Dalasanur Nagaprashantha; Sanjay Awasthi; Sharad S Singhal
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

10.  Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.

Authors:  Christoph Wiesinger; Markus Kunze; Günther Regelsberger; Sonja Forss-Petter; Johannes Berger
Journal:  J Biol Chem       Date:  2013-05-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.